ALYSSA SHEPHERD: Open Payments
NPI 1447853569 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$108 in 7 payments from 4 companies in 2025. Trend: 2023 $17 · 2024 $0 · 2025 $108
Food & beverage: $108
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 2 | $27 |
| ABBVIE INC. | 1 | $14 |
Products named: Veozah, FANAPT, Auvelity, QULIPTA.
Industry payments across IN — which companies pay providers there.
